Skip to main content

Coronavirus: Vaccination

Question for Department of Health and Social Care

UIN 117120, tabled on 2 February 2022

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure adverse reactions to covid-19 vaccinations are appropriately (a) reported and (b) monitored.

This answer is the replacement for a previous holding answer.

Answered on

9 February 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of vaccines used in the United Kingdom vaccination programme. This is based on a range of sources, including spontaneous adverse drug reaction data from the UK’s Yellow Card scheme and other global regulators, with data on vaccine exposure from public health partners and information from epidemiological studies. The MHRA’s scientists review information on a daily basis for safety issues or unexpected rare events. This enables rapid detection of any new risks, weighed against the expected benefits. The weekly Yellow Card report summarises information on COVID-19 vaccines received via the scheme and includes the findings of safety investigations carried out by the MHRA.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.